Hls Therapeutics Inc(HLS-T)TSX
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
Hls Therapeutics Inc
10 Carlson CourtSuite 701
Etobicoke ON M9W 6L2 CAN
P: 647-495-9000
F: 416-213-0045
https://www.hlstherapeutics.com
Profile
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, CSAN Pronto, and others. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, and the United States, and the Rest of the world.
Key Executives
| Name | Title |
|---|---|
| Jason Gross | Vice President, Divisional |
| John Hanna | CFO/Director |
| Ryan C. Lennox | Secretary/Senior VP, Divisional |
| Craig Stuart Millian | CEO/Director |
| Brian T. Walsh | Senior VP, Divisional |